| Product Code: ETC13272942 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Endoscopic Retrograde Cholangiopancreatography and Percutaneous Transhepatic Cholangiography Devices Market was valued at USD 0.6 Billion in 2024 and is expected to reach USD 1.1 Billion by 2031, growing at a compound annual growth rate of 8.00% during the forecast period (2025-2031).
The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market is experiencing steady growth due to the increasing prevalence of conditions such as bile duct stones, pancreatic cancer, and other biliary disorders. The market is driven by technological advancements in endoscopic and percutaneous procedures, growing awareness among healthcare professionals, and rising demand for minimally invasive diagnostic and therapeutic interventions. Key players in the market are investing in research and development to introduce innovative devices with improved efficiency and patient outcomes. Geographically, North America and Europe dominate the market due to well-established healthcare infrastructure and high adoption rates of advanced medical technologies. However, emerging economies in Asia-Pacific and Latin America are expected to witness significant growth opportunities in the coming years as healthcare infrastructure continues to improve and awareness about these procedures increases.
The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market is experiencing significant growth driven by the rising prevalence of pancreatic and biliary disorders, technological advancements in endoscopy and imaging systems, and increasing demand for minimally invasive procedures. Key trends in the market include the development of advanced ERCP and PTC devices with improved imaging capabilities and navigation tools, the integration of artificial intelligence for enhanced diagnosis and treatment planning, and the expansion of healthcare infrastructure in emerging economies. Opportunities in the market lie in the adoption of innovative devices for early diagnosis and treatment of complex biliary and pancreatic diseases, strategic partnerships for product development, and the growing demand for specialized endoscopic procedures in both diagnostic and therapeutic applications.
The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market faces challenges such as stringent regulatory requirements for device approval, high cost of procedures leading to limited accessibility in developing regions, and the risk of complications associated with these invasive procedures. Additionally, the market is witnessing increasing competition from alternative non-invasive diagnostic techniques, which may hinder the growth of ERCP and PTC devices. Furthermore, the lack of skilled healthcare professionals proficient in performing these procedures poses a significant challenge, impacting the adoption rate of these devices. Overall, navigating through these challenges requires innovative technological advancements, strategic collaborations, and targeted market expansion efforts to drive growth in the Global ERCP and PTC Devices Market.
The Global Endoscopic Retrograde Cholangiopancreatography and Percutaneous Transhepatic Cholangiography Devices Market is primarily driven by the increasing prevalence of diseases such as gallstones, pancreatitis, and bile duct obstructions, which require diagnostic and therapeutic interventions. Advancements in endoscopic imaging technologies and minimally invasive procedures have also fueled the demand for these devices. Additionally, the rising adoption of these techniques due to their effectiveness in diagnosing and treating biliary and pancreatic disorders, along with the growing geriatric population worldwide, are contributing to the market growth. Furthermore, the expanding healthcare infrastructure in emerging economies and the growing awareness among patients regarding the benefits of early diagnosis and treatment are expected to further propel the market for endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography devices.
Government policies related to the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) devices market primarily focus on ensuring the safety, efficacy, and quality of these devices. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU have established stringent regulations for the approval and monitoring of ERCP and PTC devices. These regulations include pre-market approval processes, post-market surveillance, and compliance with Good Manufacturing Practices (GMP). Additionally, reimbursement policies by government healthcare programs play a significant role in the adoption and utilization of these devices, with coverage decisions often based on clinical evidence of effectiveness and cost-effectiveness. Overall, government policies aim to promote innovation while safeguarding patient health and ensuring the appropriate use of ERCP and PTC devices in healthcare settings.
The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market is expected to witness steady growth in the coming years due to the increasing prevalence of pancreatic and biliary diseases, advancements in endoscopic technology, and rising demand for minimally invasive procedures. The market is anticipated to be driven by the growing aging population, higher adoption of ERCP and PTC procedures, and expanding healthcare infrastructure in emerging economies. Additionally, technological innovations such as the integration of artificial intelligence and robotic-assisted procedures are likely to further propel market growth. However, challenges such as high costs associated with devices and limited access to advanced healthcare facilities in certain regions may hinder market expansion to some extent. Overall, the market is poised for continued growth and innovation in the foreseeable future.
In the Global Endoscopic Retrograde Cholangiopancreatography and Percutaneous Transhepatic Cholangiography Devices Market, Asia Pacific is expected to witness significant growth due to the increasing prevalence of gastrointestinal disorders and the rising adoption of advanced medical technologies in countries like China and India. North America holds a prominent market share, driven by a well-established healthcare infrastructure, technological advancements, and high healthcare expenditure. Europe is also a key market, with a growing elderly population and a high incidence of liver and pancreatic diseases driving market growth. In the Middle East and Africa region, the market is poised for growth due to improving healthcare infrastructure and increasing awareness about minimally invasive procedures. Latin America is witnessing steady growth, attributed to rising healthcare investments and the presence of key market players expanding their operations in the region.
Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market - Industry Life Cycle |
3.4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market - Porter's Five Forces |
3.5 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Trends |
6 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, 2021 - 2031 |
6.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Sphincterotomes, 2021 - 2031 |
6.1.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Lithotripter, 2021 - 2031 |
6.1.4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Endoscopes, 2021 - 2031 |
6.1.5 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Accessories, 2021 - 2031 |
6.1.6 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Stents, 2021 - 2031 |
6.1.7 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Cannulas, 2021 - 2031 |
6.1.8 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Forceps, 2021 - 2031 |
6.1.9 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Jaundice, 2021 - 2031 |
6.2.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Stone Removal, 2021 - 2031 |
6.2.4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Postoperative or Posttraumatic Bile Leakage, 2021 - 2031 |
6.2.5 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Pancreatitis, 2021 - 2031 |
6.2.6 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Hositals, 2021 - 2031 |
6.3.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.3.5 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Overview & Analysis |
7.1 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume, 2021 - 2031 |
7.2 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
8 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
9 Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Overview & Analysis |
9.1 Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
10 Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Overview & Analysis |
10.1 Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
11 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Overview & Analysis |
11.1 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
12 Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Overview & Analysis |
12.1 Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, Revenues & Volume, By End users, 2021 - 2031 |
13 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Key Performance Indicators |
14 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market - Export/Import By Countries Assessment |
15 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market - Opportunity Assessment |
15.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Opportunity Assessment, By End users, 2021 & 2031F |
16 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market - Competitive Landscape |
16.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Revenue Share, By Companies, 2024 |
16.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |